Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

1.

The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009-2015).

Katz KC, Golding GR, Choi KB, Pelude L, Amaratunga KR, Taljaard M, Alexandre S, Collet JC, Davis I, Du T, Evans GA, Frenette C, Gravel D, Hota S, Kibsey P, Langley JM, Lee BE, Lemieux C, Longtin Y, Mertz D, Mieusement LMD, Minion J, Moore DL, Mulvey MR, Richardson S, Science M, Simor AE, Stagg P, Suh KN, Taylor G, Wong A, Thampi N; Canadian Nosocomial Infection Surveillance Program.

CMAJ. 2018 Jun 25;190(25):E758-E765. doi: 10.1503/cmaj.180013.

2.

Human granulocytic anaplasmosis acquired from a blacklegged tick in Ontario.

Edginton S, Guan TH, Evans G, Srivastava S.

CMAJ. 2018 Mar 26;190(12):E363-E366. doi: 10.1503/cmaj.171243. No abstract available.

PMID:
29581163
3.

Longitudinal Multicenter Analysis of Outcomes After Cessation of Control Measures for Vancomycin-Resistant Enterococci.

Lemieux C, Gardam M, Evans G, John M, Suh KN, vanWalraven C, Vicencio E, Coulby C, Roth V, Hota S.

Infect Control Hosp Epidemiol. 2017 Jan;38(1):24-30. doi: 10.1017/ice.2016.235. Epub 2016 Nov 2.

PMID:
27804901
4.

Guidance on the use of antiviral drugs for influenza in acute care facilities in Canada, 2014-2015.

Stiver HG, Evans GA, Aoki FY, Allen UD, Laverdière M.

Can J Infect Dis Med Microbiol. 2015 Jan-Feb;26(1):e5-8.

5.

Guidance for practitioners on the use of antiviral drugs to control influenza outbreaks in long-term care facilities in Canada, 2014-2015 season.

Aoki FY, Allen UD, Stiver HG, Laverdière M, Skowronski D, Evans GA.

Can J Infect Dis Med Microbiol. 2015 Jan-Feb;26(1):e1-4.

6.

The need for transparency and efficiency in reimbursement decisions relating to drugs for rare diseases.

Coyle DA, Cheung MC, Evans GA.

Med Decis Making. 2015 Feb;35(2):145-7. doi: 10.1177/0272989X14563082. Epub 2014 Dec 10. No abstract available.

PMID:
25505026
7.

Toward a functional definition of a "rare disease" for regulatory authorities and funding agencies.

Clarke JT, Coyle D, Evans G, Martin J, Winquist E.

Value Health. 2014 Dec;17(8):757-61. doi: 10.1016/j.jval.2014.08.2672. Epub 2014 Oct 18.

8.

A confusing case - Weissella confusa prosthetic joint infection: A case report and review of the literature.

Medford R, Patel SN, Evans GA.

Can J Infect Dis Med Microbiol. 2014 May;25(3):173-5.

9.

Renal failure, hepatitis and myocarditis in a previously healthy man.

Climans SA, Murphy JM, Evans GA, Shamseddin MK.

Can J Infect Dis Med Microbiol. 2014 May;25(3):133-4. No abstract available.

10.

Application of a policy framework for the public funding of drugs for rare diseases.

Winquist E, Coyle D, Clarke JT, Evans GA, Seager C, Chan W, Martin J.

J Gen Intern Med. 2014 Aug;29 Suppl 3:S774-9. doi: 10.1007/s11606-014-2885-y.

11.

Opportunity cost of funding drugs for rare diseases: the cost-effectiveness of eculizumab in paroxysmal nocturnal hemoglobinuria.

Coyle D, Cheung MC, Evans GA.

Med Decis Making. 2014 Nov;34(8):1016-29. doi: 10.1177/0272989X14539731. Epub 2014 Jul 2.

PMID:
24990825
12.

Microbial source tracking and spatial analysis of E. coli contaminated private well waters in southeastern Ontario.

Krolik J, Evans G, Belanger P, Maier A, Hall G, Joyce A, Guimont S, Pelot A, Majury A.

J Water Health. 2014 Jun;12(2):348-57. doi: 10.2166/wh.2013.192.

PMID:
24937229
13.

The Vioxx® legacy: Enduring lessons from the not so distant past.

McIntyre WF, Evans G.

Cardiol J. 2014;21(2):203-5. doi: 10.5603/CJ.2014.0029. No abstract available.

PMID:
24752949
14.

Emergency department surveillance as a proxy for the prediction of circulating respiratory viral disease in Eastern Ontario.

Hall G, Krahn T, Van Dijk A, Evans G, Moore K, Maier A, Majury A.

Can J Infect Dis Med Microbiol. 2013 Fall;24(3):150-4. Erratum in: Can J Infect Dis Med Microbiol. 2013 Winter;24(4):240.

15.

The velvet myocardium: potential harbinger of death in acute myocarditis?

Johri AM, Barake W, Crawford B, Turashvili G, Rossiter J, Evans GA.

Can J Cardiol. 2013 Dec;29(12):1742.e25-7. doi: 10.1016/j.cjca.2013.09.007.

PMID:
24267815
16.

A spatial analysis of private well water Escherichia coli contamination in southern Ontario.

Krolik J, Maier A, Evans G, Belanger P, Hall G, Joyce A, Majury A.

Geospat Health. 2013 Nov;8(1):65-75.

17.

An evaluation framework for funding drugs for rare diseases.

Winquist E, Bell CM, Clarke JT, Evans G, Martin J, Sabharwal M, Gadhok A, Stevenson H, Coyle D.

Value Health. 2012 Sep-Oct;15(6):982-6. doi: 10.1016/j.jval.2012.06.009.

18.

A survey of national physicians working in an active conflict zone: the challenges of emergency medical care in Iraq.

Donaldson RI, Shanovich P, Shetty P, Clark E, Aziz S, Morton M, Hasoon T, Evans G.

Prehosp Disaster Med. 2012 Apr;27(2):153-61. doi: 10.1017/S1049023X12000519. Epub 2012 May 17.

PMID:
22591705
19.

Iraqi community members' knowledge, attitude and practice of emergency medical care: assessing civilian emergency medicine in an area of conflict.

Shanovich PK, Donaldson RI, Hung YW, Hasoon T, Evans GE.

Med Confl Surviv. 2011 Jul-Sep;27(3):151-64.

PMID:
22320014
20.

AMMI Canada position paper: 2012 Mandatory influenza immunization of health care workers.

Bryce E, Embree J, Evans G, Johnston L, Katz K, McGeer A, Moore D, Roth V, Simor A, Suh K, Vearncombe M.

Can J Infect Dis Med Microbiol. 2012 Winter;23(4):e93-5. No abstract available.

Supplemental Content

Loading ...
Support Center